Agilent Technologies stock dips after insider buy and Q3 earnings strength
Published on 09/10/2026 at 20:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Agilent Technologies stock (ISIN US00846U1016) is changing hands near USD 144.75 on September 10, 2026, leaving the life science and diagnostics specialist valued at about USD 40.2 billion on the New York Stock Exchange.
Insider purchase adds a signal
According to Benzinga on September 10, 2026, Agilent Technologies director Glenn Boehnlein purchased 817 shares of the company, a transaction worth USD 119,976 based on the disclosed Form 4 filing with the U.S. Securities and Exchange Commission.
The same report notes that Agilent Technologies shares were down 1.2 percent in Thursday morning trading, quoted at USD 144.75, which puts the insider purchase close to the prevailing market price on September 10, 2026.
Q3 2026 earnings show solid growth
As Yahoo Finance reports, Agilent Technologies announced strong Q3 2026 earnings with revenue of USD 1.88 billion, reflecting 7.3 percent core growth versus the prior-year quarter, underscoring a healthy expansion in its measurement and diagnostics businesses.
The same overview highlights a trailing twelve-month revenue base of USD 7.37 billion and net income attributable to common shareholders of USD 1.44 billion, translating into a profit margin of 19.53 percent for the period covered, which is a key indicator of the company’s ability to convert sales into earnings.
Agilent’s diluted earnings per share over the trailing twelve months stand at USD 5.07, and the stock trades at a trailing price-to-earnings ratio of 28.11 based on this EPS and the current share price, a valuation level that investors can compare with peers in the healthcare and life science tools sector.
The Q3 2026 performance also feeds into a broader profitability and balance-sheet picture: return on equity of 20.97 percent and levered free cash flow of USD 1.06 billion over the trailing twelve months demonstrate that the company is generating meaningful returns on capital while maintaining cash generation capacity.
Analyst targets and valuation context
According to the analyst snapshot on Yahoo Finance, Morningstar currently assigns Agilent Technologies an investment rating of Buy with a price target of USD 162.00, while Argus also rates the shares Buy with a price target of USD 165.00, both published in early September 2026.
With the stock around USD 144.75 as of September 10, 2026, the Morningstar target implies potential upside of about 11.9 percent and the Argus target implies roughly 14 percent relative to the present level, giving investors a quantified sense of how these houses view the risk-reward profile.
The same data set lists a one-year consensus target estimate of USD 175.45, which, if reached, would represent an increase of about 21.2 percent from the current price, though such consensus figures always depend on future execution and market conditions.
Agilent’s valuation metrics complement these targets: a price-to-sales ratio of 5.57 and an enterprise-value-to-EBITDA multiple of 21.13 are both derived from the latest trailing data on Yahoo Finance, suggesting that the market is paying a premium for its growth and margins compared with many diversified industrials.
Stock trades below 52-week high
Per the same NYSE quote overview on Yahoo Finance, Agilent Technologies shares have traded in a 52-week range between USD 108.35 and USD 163.75, with the current level of around USD 144.75 sitting roughly 11.6 percent below the 52-week high and about 33.6 percent above the 52-week low.
The same data show a previous close of USD 144.75 and an opening price of USD 142.58 for the latest trading session, with an intraday range between USD 141.25 and USD 144.15 and volume around 747,678 shares, compared with an average daily volume near 2,207,275 shares.
With an intraday market capitalization of approximately USD 40.186 billion as of September 10, 2026, Agilent Technologies remains one of the larger players in the life sciences tools and diagnostics segment, competing with other global measurement and lab equipment providers.
Balance sheet and dividend details
The balance-sheet snapshot on Yahoo Finance indicates total cash of about USD 1.76 billion and a total debt-to-equity ratio of 56.34 percent, a combination that points to moderate leverage and financial flexibility for continued investment in R&D and potential acquisitions.
Agilent Technologies also returns cash to shareholders through dividends: the forward annual dividend is listed at USD 1.02 per share, corresponding to a yield of around 0.70 percent at the current price, and the most recent ex-dividend date was June 30, 2026, providing an additional, albeit modest, income component to the total return profile.
For investors following upcoming catalysts, the earnings calendar embedded in the quote page cites an estimated next earnings date of November 25, 2026, which would likely correspond to the company’s next quarterly update and thus a key checkpoint for tracking whether the Q3 2026 growth trends are sustained.
Closing look at Agilent Technologies stock
On the New York Stock Exchange, Agilent Technologies stock recently traded in a narrow band around USD 144.75 on September 10, 2026, against a 52-week high of USD 163.75 and a low of USD 108.35, leaving the shares valued at just over USD 40 billion and offering investors a mix of insider activity, double-digit profit margins and mid-teens percentage upside to key analyst price targets.
Agilent Technologies stock facts
- Company: Agilent Technologies, Inc.
- ISIN: US00846U1016
- Ticker: A
- Trading venue: NYSE
- Price (as of September 10, 2026): 144.75 USD
- Market capitalization: 40.186 billion USD (as of September 10, 2026)
- Sector / Industry: Health Care / Life Sciences Tools and Services
- Index membership: S&P 500
- Next earnings date: November 25, 2026
